BA
AXDX

BlackRock Advisors’s Accelerate Diagnostics AXDX Stock Holding History

BlackRock Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$249K Sell
1,198
-14
-1% -$3.32K ﹤0.01% 2597
2016
Q3 		$330K Buy
1,212
+123
+11% +$27.2K ﹤0.01% 2397
2016
Q2 		$157K Sell
1,089
-65
-6% -$8.72K ﹤0.01% 2743
2016
Q1 		$166K Buy
1,154
+164
+17% +$23.1K ﹤0.01% 2659
2015
Q4 		$213K Sell
990
-453
-31% -$82.7K ﹤0.01% 2532
2015
Q3 		$234K Buy
1,443
+1
+0.1% +$216 ﹤0.01% 2628
2015
Q2 		$372K Buy
1,442
+135
+10% +$32.2K ﹤0.01% 2398
2015
Q1 		$294K Buy
1,307
+181
+16% +$37.8K ﹤0.01% 2462
2014
Q4 		$216K Sell
1,126
-62
-5% -$13.3K ﹤0.01% 2581
2014
Q3 		$255K Buy
1,188
+229
+24% +$44.5K ﹤0.01% 2450
2014
Q2 		$249K Buy
959
+383
+66% +$83.6K ﹤0.01% 2498
2014
Q1 		$126K Buy
576
+37
+7% +$5.48K ﹤0.01% 2917
2013
Q4 		$66K Buy
539
+42
+8% +$5.61K ﹤0.01% 3178
2013
Q3 		$67K Buy
497
+30
+6% +$2.68K ﹤0.01% 3111
2013
Q2 		$38K Buy
+467
New +$34.7K ﹤0.01% 3209

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BlackRock Advisors's AXDX Position: Q4 2016 in Review

BlackRock Advisors reduced its Accelerate Diagnostics (AXDX) stake by 1.2% in Q4 2016, selling an estimated $3.32K and leaving 1,198 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #2597.

BlackRock Advisors first reported a position in AXDX in Q2 2013 and has held it in 15 quarters since. The position peaked at $372K in Q2 2015. 109 funds tracked by Wall St. Rank hold AXDX as of Q4 2016.

  • BlackRock Advisors held 1,198 shares of Accelerate Diagnostics worth $249K as of Q4 2016.
  • BlackRock Advisors sold 14 Accelerate Diagnostics shares in Q4 2016, an estimated $3.32K.
  • Accelerate Diagnostics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2597 holding.
  • BlackRock Advisors first reported a position in Accelerate Diagnostics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Accelerate Diagnostics position peaked at $372K in Q2 2015.
  • 109 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.